Pre clinical models Flashcards
(48 cards)
what is rituximab?
Human CD20 mAb - the first monoclonal approved for treatment of cancer (B cell malignancies)
Targets CD20
Since treated millions, generating 6-7billion dollars a year
now used to treat and expanding number of autoimmune disorders
patients can develop resistance
what is the most important method of killing by rituximab?
Ab- mediated killing
what are the activating Fc receptor names? in mice
FcγR1, FcγR3, FcγR4
what is the inhibitory Fc receptor name? in mice
FcγR2B
what are the activating Fc receptors in humans
FcγR1, FcγR2A, FcγR2C, FcγR3A, FcγR3B
what antibody subclass is the basis for rituximab?
IgG
how do Fc receptors contribute to the tumour microenvironment?
Footnote
depening on the balance of activating and inhibiting Fc receptors present on myeloid cells there will be a skew towards proinflammatory (activating) or anti-inflammatory (inhibiting). When balanced there is homeostasis
Anti inflammatory microenvironment is suppressive and seen in the tumour
by immunoreceptor tyrosine based activator/inhibitor motif signalling
what is the mechanims of action of rituximab?
Rituximab mAB binds CD20 on the tumour cells and attracts effector cells like macrophages and natural killer cells which bind via the Fc part of the antibody which subsequently activates them to kill the tumour via phagocytosis or release of perforin (respectively)
what is the mechanism of resistance to rituximab?
Rituximab mAB binds CD20, but then flips back and binds to the inhibitory receptor Fcgamma2B on the tumor cell (by cis binding). This causes internalisation of the receptor antibody complex and subsequent degradation before it can activate effector cells
what combination therapy helps treat rituximab-resistant patients?
Rituximab (anti-hCD20) and anti-hCD32 combination
what relavent preclinical model was needed for the Rituximab (anti-hCD20) and anti-hCD32 combination therapy trial?
mice that expressed human cd20 and cd32b and lack the mice genes
what pharmacodynamics/kinetics were performed on antiCD32B mAb?
half life at different dosages, % circulating B cells, % splenic B cells,
what factors were part of the safety profile for antiCD32B mAb
mouse weight, cytokine concentration
what are patient-derived xenograft (PDX) models?
Patient-derived xenograft (PDX) models are models of cancer where the tissue or cells from a patient’s tumor are implanted into an immunedeficient or humanized mouse. PDX models simulate human tumor biology allowing for natural cancer progression, and offer the most translational research model for evaluating efficacy.
how do you create a PDX model?
take tumour from a patient, inject a small portion into immunocompromised mice (inject into subcutaneous or mammary fat and (depending on original tissue the tumour was taken from)
flow cytometry to assess status and phenotype of the cell
what stage of development are the antiCD32b mAb at?
phase 1/2 clinical trials in UK and USA
describe how humanised mice are made
how did scienctists overcome the tumour resistance to rituximab?
by inhibiting the inhibitory receptor
unfortunately they couldn’t target the entire receptor due to 98% homology of the extracellular domain of CD32B (FcR2B) and CD32A (FcR2A) which is an activator receptor.
So instead they identified unique epilogs that could be targeted to areas specific to CD32B and not present in CD32A and bound by antibodies
how do you create a humanised mouse model?
take a sample of peripheral blood, cord blood or fetal liver and idolate CD34+ Haematopoietic stem cell
what mouse model was used in the research fro antiCD32B antibodies?
A mouse that lacked the mice genes for Fc but has the human Fc genes specifically human CD20 and CD32A and B
describe the research that investigated rituximab (anti-hCD20) and anti-hCD32 combination therapy in vivo
Southampton Project started in 2009/10
Teamed up with company.
To identify which antibodies were successfull in overcoming the resistance to rituximab
Relevant pre clinical models needed
Used mice that expressed human cd20 and cd32b and lack the mice genes for Fc but have the human Fcs
Monotherapy, Each independently then combine together
Depletion of B cells is extended by two weeks when the therapies were combined
Then the pharmacodynamics
Then measured the depletion of B cells- dose dependent over time
Also analysed safety, kept an eye on general health and weight
what is patient matched co-engraftment
when part of the tumor AND the other cells (eg CAFs, immune infiltrate) are injected into the mouse
what is a common method to assess status and phenotype of cells within a model system?
Flow cytometry
what are the benefits of immunodeficient mouse hosts for research
- enables long term experiments
superior ability to be humanised: excellent engraftment and differentiation of human hematopoietic stem cells into mature human lymphoid and myeloid cells
superior for HIV and other infectious disease research: can essentially be engrafted with a human immune system